CO5440228A1 - URINARY INCONTINENCE TREATMENT - Google Patents

URINARY INCONTINENCE TREATMENT

Info

Publication number
CO5440228A1
CO5440228A1 CO00063066A CO00063066A CO5440228A1 CO 5440228 A1 CO5440228 A1 CO 5440228A1 CO 00063066 A CO00063066 A CO 00063066A CO 00063066 A CO00063066 A CO 00063066A CO 5440228 A1 CO5440228 A1 CO 5440228A1
Authority
CO
Colombia
Prior art keywords
urinary incontinence
respect
muscarinic receptors
treatment
incontinence treatment
Prior art date
Application number
CO00063066A
Other languages
Spanish (es)
Inventor
Gupta Sandeep
Original Assignee
Lunbeck As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunbeck As H filed Critical Lunbeck As H
Publication of CO5440228A1 publication Critical patent/CO5440228A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica para el tratamiento de la vejiga sobreactiva o inestable, que incluye el tratamiento de la incontinencia urinaria, que comprende por lo menos un compuesto que es un agonista o un agonista parcial con respecto a los receptores muscarinicos M1, un antagonista con respecto a los receptores muscarínicos M3 y preferentemente también un antagonista con respecto a los recptores muscarínicos M2, y sus vehículos o diluyentes farmacéuticamente aceptables. <EMI FILE="00063066_1" ID="1" IMF=JPEG >A pharmaceutical composition for the treatment of overactive or unstable bladder, which includes the treatment of urinary incontinence, which comprises at least one compound that is an agonist or partial agonist with respect to M1 muscarinic receptors, an antagonist with respect to M3 muscarinic receptors and preferably also an antagonist with respect to M2 muscarinic receptors, and their pharmaceutically acceptable carriers or diluents. <EMI FILE = "00063066_1" ID = "1" MFI = JPEG>

CO00063066A 1999-08-23 2000-08-23 URINARY INCONTINENCE TREATMENT CO5440228A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199901157 1999-08-23

Publications (1)

Publication Number Publication Date
CO5440228A1 true CO5440228A1 (en) 2004-09-30

Family

ID=8101650

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00063066A CO5440228A1 (en) 1999-08-23 2000-08-23 URINARY INCONTINENCE TREATMENT

Country Status (4)

Country Link
AR (1) AR025353A1 (en)
AU (1) AU6686700A (en)
CO (1) CO5440228A1 (en)
WO (1) WO2001013918A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4174673B2 (en) * 2001-07-10 2008-11-05 アステラス製薬株式会社 Pharmaceutical composition for the treatment of interstitial cystitis
FR2910814B1 (en) * 2006-12-28 2011-06-17 Pf Medicament USE OF 10- (R3) -1-AZABICYCLO2.2.2-OCT-3-YLMETHYL-10H-PHENOTHIAZINE FOR THE PREPARATION OF A MEDICAMENT EXERCISING SELECTIVE INHIBITION OF M1,2,3 MUSCARINIC RECEPTORS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
CA2234619A1 (en) * 1995-10-13 1997-04-17 Morihiro Mitsuya Substituted heteroaromatic ring derivatives
PE92198A1 (en) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd DERIVATIVES OF FLUORINE-CONTAINED 1,4-PIPERIDINE

Also Published As

Publication number Publication date
WO2001013918A1 (en) 2001-03-01
AR025353A1 (en) 2002-11-20
AU6686700A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
CO5271657A1 (en) DERIVATIVES OF AZAINDOL
CO5690131A1 (en) DERIVATIVES OF ETER BIARILICO PRESENTING ACTIVITY AS INHIBITORS OF THE RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS
CO5070656A1 (en) RAPAMYCIN ANALOGS CONTAINING TETRAZOL WITH MORE SHORT PERIODS OF LIFE
CO5160257A1 (en) N-PIPERIDINO-5- (4-BROMOFENIL) -1- (2,4-DICLOROPHENIL) -4-ETILPIRAZOL-3-CARBOXAMIDE, ITS SALTS, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
SV2003000633A (en) NEW TIADIAZOLS AND OXADIAZOLS AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASA-7
CO5570109A1 (en) HETEROCICLIC DIHYDROPIRIMIDINE COMPOUNDS
CO5680428A2 (en) THROMBINE RECEIVER ANTAGONISTS
CO5150238A1 (en) TELMISARTAN POLYMORPHES, PROCEDURE FOR PREPARATION AND USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
CO5280206A1 (en) PHARMACEUTICAL FORMULATION OF SUSTAINED LIBERATION ADAPTED FOR INJECTION ADMINISTRATION
AR027065A1 (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POWERFUL FARMACO CONCENTRATIONS
EP1762236A3 (en) Formulations of alpha adrenergic receptor antagonists and their uses
CO5280060A1 (en) BICYCLE AMINO ACIDS AS PHARMACEUTICAL AGENTS
KR930023340A (en) Arylacetamide
CO5160329A1 (en) METHOD FOR PROVIDING INCREASED ABSORPTION OF A PHARMACEUTICALLY ACCEPTABLE AMINA IN THE BLOOD OF A HUMAN AND COMPOSITION THAT INCLUDES A PHARMACEUTICALLY AMINE A NON-STEROID ANTI-INFLAMMATORY PHARMACO
BR0317322A (en) Polyethylene molding composition, and process for the production and use thereof
CO5271716A1 (en) CRYSTALS OF 4- CARBOXAMINE 1,2,3,4-TETRAHYDROQUINOLINE 2- REPLACED
CO5271666A1 (en) PIRIMIDINE DERIVATIVES
CO5140075A1 (en) THERAPEUTIC AGENTS FOR THE TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS DISEASE
BR0007864A (en) Compound, and, use of a compound
CO5090829A1 (en) ORGANIC COMPOUNDS OF FORMULA I, USED AS INHIBITED RES OF THE PROTEIN OF TRANSFER OF MICROSOUS TRIGLICERIDE AND OF THE APOLIPOPROTEIN B SECRETION.
ES2187565T3 (en) USEFUL INDOLIC ALCALOIDS AS ANTI-INFLAMMATORY AGENTS.
BRPI0316895C1 (en) compound, process for preparing the compound, pharmaceutical composition and use of the compound
MXPA04000908A (en) Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use.
CO5150166A1 (en) (S) -10, 11-DIHYDRO-3 [2- (5,6,7,8-TETRAHYDRO-1,8-NAFTIRIDIN -2-IL) -ETOXI] -5H-DIBENZO [A, D] CYCLHEPTANE-10 -ACETIC ACID
CO5440228A1 (en) URINARY INCONTINENCE TREATMENT

Legal Events

Date Code Title Description
FA Application withdrawn